132 related articles for article (PubMed ID: 31851882)
1. Usefulness of Early C-Reactive Protein Kinetics in Response and Prognostic Assessment in Infected Critically Ill Patients: An Observational Retrospective Study.
Pereira MA; Rouxinol-Dias AL; Vieira T; Paiva JA; Pereira JM
Acta Med Port; 2019 Dec; 32(12):737-745. PubMed ID: 31851882
[TBL] [Abstract][Full Text] [Related]
2. C-reactive protein and albumin kinetics after antibiotic therapy in community-acquired bloodstream infection.
Póvoa P; Garvik OS; Vinholt PJ; Pedersen C; Jensen TG; Kolmos HJ; Lassen AT; Gradel KO
Int J Infect Dis; 2020 Jun; 95():50-58. PubMed ID: 32251802
[TBL] [Abstract][Full Text] [Related]
3. Usefulness of C-reactive protein in monitoring the severe community-acquired pneumonia clinical course.
Coelho L; Póvoa P; Almeida E; Fernandes A; Mealha R; Moreira P; Sabino H
Crit Care; 2007; 11(4):R92. PubMed ID: 17723153
[TBL] [Abstract][Full Text] [Related]
4. Community-acquired bloodstream infection in critically ill adult patients: impact of shock and inappropriate antibiotic therapy on survival.
Vallés J; Rello J; Ochagavía A; Garnacho J; Alcalá MA
Chest; 2003 May; 123(5):1615-24. PubMed ID: 12740282
[TBL] [Abstract][Full Text] [Related]
5. Patterns of C-reactive protein ratio predicts outcomes in healthcare-associated pneumonia in critically ill patients with cancer.
Rabello LSCF; Póvoa P; Lapa E Silva JR; Azevedo LCP; da Silva Ramos FJ; Lisboa T; Soares M; Salluh JIF
J Crit Care; 2017 Dec; 42():231-237. PubMed ID: 28797895
[TBL] [Abstract][Full Text] [Related]
6. 7 versus 14 days of antibiotic treatment for critically ill patients with bloodstream infection: a pilot randomized clinical trial.
Daneman N; Rishu AH; Pinto R; Aslanian P; Bagshaw SM; Carignan A; Charbonney E; Coburn B; Cook DJ; Detsky ME; Dodek P; Hall R; Kumar A; Lamontagne F; Lauzier F; Marshall JC; Martin CM; McIntyre L; Muscedere J; Reynolds S; Sligl W; Stelfox HT; Wilcox ME; Fowler RA;
Trials; 2018 Feb; 19(1):111. PubMed ID: 29452598
[TBL] [Abstract][Full Text] [Related]
7. Impact of inappropriate initial antibiotics in critically ill surgical patients with bacteremia.
Abraham K; Dolman HS; Zimmerman LH; Faris J; Edelman DA; Baylor A; Wilson RF; Tyburski JG
Am J Surg; 2016 Mar; 211(3):593-8. PubMed ID: 26778270
[TBL] [Abstract][Full Text] [Related]
8. Community-acquired pneumonia and survival of critically ill acute exacerbation of COPD patients in respiratory intensive care units.
Lu Z; Cheng Y; Tu X; Chen L; Chen H; Yang J; Wang J; Zhang L
Int J Chron Obstruct Pulmon Dis; 2016; 11():1867-72. PubMed ID: 27563239
[TBL] [Abstract][Full Text] [Related]
9. The utility of proadrenomedullin and procalcitonin in comparison to C-reactive protein as predictors of sepsis and bloodstream infections in critically ill patients with cancer*.
Debiane L; Hachem RY; Al Wohoush I; Shomali W; Bahu RR; Jiang Y; Chaftari AM; Jabbour J; Al Shuaibi M; Hanania A; Pravinkumar SE; Schuetz P; Raad I
Crit Care Med; 2014 Dec; 42(12):2500-7. PubMed ID: 25083975
[TBL] [Abstract][Full Text] [Related]
10. Mid-regional proadrenomedullin: An early marker of response in critically ill patients with severe community-acquired pneumonia?
Pereira JM; Azevedo A; Basílio C; Sousa-Dias C; Mergulhão P; Paiva JA
Rev Port Pneumol (2006); 2016; 22(6):308-314. PubMed ID: 27160747
[TBL] [Abstract][Full Text] [Related]
11. Timing of appropriate empirical antimicrobial administration and outcome of adults with community-onset bacteremia.
Lee CC; Lee CH; Hong MY; Tang HJ; Ko WC
Crit Care; 2017 May; 21(1):119. PubMed ID: 28545484
[TBL] [Abstract][Full Text] [Related]
12. C-reactive protein correlates with bacterial load and appropriate antibiotic therapy in suspected ventilator-associated pneumonia.
Lisboa T; Seligman R; Diaz E; Rodriguez A; Teixeira PJ; Rello J
Crit Care Med; 2008 Jan; 36(1):166-71. PubMed ID: 18007271
[TBL] [Abstract][Full Text] [Related]
13. Can we predict pneumococcal bacteremia in patients with severe community-acquired pneumonia?
Pereira JM; Teixeira-Pinto A; Basílio C; Sousa-Dias C; Mergulhão P; Paiva JA
J Crit Care; 2013 Dec; 28(6):970-4. PubMed ID: 24216331
[TBL] [Abstract][Full Text] [Related]
14. C-reactive protein, an early marker of community-acquired sepsis resolution: a multi-center prospective observational study.
Póvoa P; Teixeira-Pinto AM; Carneiro AH;
Crit Care; 2011 Jul; 15(4):R169. PubMed ID: 21762483
[TBL] [Abstract][Full Text] [Related]
15. Clinical characteristics and outcome of critically ill patients with bacteremia caused by extended-spectrum β-lactamase-producing and non-producing Escherichia coli.
Haruki Y; Hagiya H; Haruki M; Sugiyama T
J Infect Chemother; 2018 Nov; 24(11):944-947. PubMed ID: 29803763
[TBL] [Abstract][Full Text] [Related]
16. Usefulness of consecutive C-reactive protein measurements in follow-up of severe community-acquired pneumonia.
Bruns AH; Oosterheert JJ; Hak E; Hoepelman AI
Eur Respir J; 2008 Sep; 32(3):726-32. PubMed ID: 18508833
[TBL] [Abstract][Full Text] [Related]
17. Utility of procalcitonin, C-reactive protein and white blood cells alone and in combination for the prediction of clinical outcomes in community-acquired pneumonia.
Zhydkov A; Christ-Crain M; Thomann R; Hoess C; Henzen C; Werner Z; Mueller B; Schuetz P;
Clin Chem Lab Med; 2015 Mar; 53(4):559-66. PubMed ID: 25014522
[TBL] [Abstract][Full Text] [Related]
18. Procalcitonin, mid-regional proadrenomedullin and C-reactive protein in predicting treatment outcome in community-acquired febrile urinary tract infection.
Stalenhoef JE; van Nieuwkoop C; Wilson DC; van der Starre WE; van der Reijden TJK; Delfos NM; Leyten EMS; Koster T; Ablij HC; van 't Wout JJW; van Dissel JT
BMC Infect Dis; 2019 Feb; 19(1):161. PubMed ID: 30764769
[TBL] [Abstract][Full Text] [Related]
19. Patterns of c-reactive protein RATIO response in severe community-acquired pneumonia: a cohort study.
Coelho LM; Salluh JI; Soares M; Bozza FA; Verdeal JC; Castro-Faria-Neto HC; Lapa e Silva JR; Bozza PT; Póvoa P
Crit Care; 2012 Dec; 16(2):R53. PubMed ID: 22449513
[TBL] [Abstract][Full Text] [Related]
20. Evolution over a 15-year period of the clinical characteristics and outcomes of critically ill patients with severe community-acquired pneumonia.
Vallés J; Diaz E; Martín-Loeches I; Bacelar N; Saludes P; Lema J; Gallego M; Fontanals D; Artigas A
Med Intensiva; 2016 May; 40(4):238-45. PubMed ID: 26391738
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
